Ligand chain length drives activation of lipid G protein-coupled receptors
暂无分享,去创建一个
Leonardo Pardo | Julian Zachmann | Inés González-Gil | L. Pardo | C. Govaerts | M. López-Rodríguez | S. Ortega‐Gutiérrez | Silvia Ortega-Gutiérrez | Ángel González | J. Zachmann | Angel Gonzalez | Cedric Govaerts | Anastassia Troupiotis-Tsaïlaki | Maria L. López-Rodríguez | I. González-Gil | Anastassia Troupiotis-Tsaïlaki
[1] H. Schiöth,et al. The Repertoire of G-Protein–Coupled Receptors in Fully Sequenced Genomes , 2005, Molecular Pharmacology.
[2] Michael D. Davis,et al. Synthesis and biological evaluation of gamma-aminophosphonates as potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonists. , 2007, Bioorganic & medicinal chemistry.
[3] Shuguang Yuan,et al. Lipid Receptor S1P1 Activation Scheme Concluded from Microsecond All-Atom Molecular Dynamics Simulations , 2013, PLoS Comput. Biol..
[4] Thomas M Frimurer,et al. A Conserved Aromatic Lock for the Tryptophan Rotameric Switch in TM-VI of Seven-transmembrane Receptors* , 2009, The Journal of Biological Chemistry.
[5] A. Sali,et al. Comparative protein structure modeling of genes and genomes. , 2000, Annual review of biophysics and biomolecular structure.
[6] S. Katsumura,et al. Versatile synthetic method for sphingolipids and functionalized sphingosine derivatives via olefin cross metathesis. , 2006, Organic letters.
[7] S. Rasmussen,et al. Structure of a nanobody-stabilized active state of the β2 adrenoceptor , 2010, Nature.
[8] J. Ballesteros,et al. Beta2 adrenergic receptor activation. Modulation of the proline kink in transmembrane 6 by a rotamer toggle switch. , 2002, The Journal of biological chemistry.
[9] K Schulten,et al. VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.
[10] L. Pardo,et al. Mechanism of N-terminal modulation of activity at the melanocortin-4 receptor GPCR. , 2012, Nature chemical biology.
[11] L. Pardo,et al. Linking agonist binding to histamine H1 receptor activation , 2005, Nature chemical biology.
[12] H. Hartung,et al. Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis , 2010, Clinical neuropharmacology.
[13] Michael D. Davis,et al. Sphingosine 1-Phosphate Analogs as Receptor Antagonists* , 2005, Journal of Biological Chemistry.
[14] C. Chalfant,et al. Sphingolipids as Signaling and Regulatory Molecules , 2010 .
[15] J. Bockaert,et al. Molecular tinkering of G protein‐coupled receptors: an evolutionary success , 1999, The EMBO journal.
[16] Y. Fujiwara,et al. Identification of the Hydrophobic Ligand Binding Pocket of the S1P1 Receptor* , 2007, Journal of Biological Chemistry.
[17] Jens Meiler,et al. Structure of a Class C GPCR Metabotropic Glutamate Receptor 1 Bound to an Allosteric Modulator , 2014, Science.
[18] Leonardo Pardo,et al. Influence of the g- conformation of Ser and Thr on the structure of transmembrane helices. , 2010, Journal of structural biology.
[19] Mihaly Mezei,et al. Simulaid: A simulation facilitator and analysis program , 2010, J. Comput. Chem..
[20] B. Kobilka,et al. Energy landscapes as a tool to integrate GPCR structure, dynamics, and function. , 2010, Physiology.
[21] Sebastian Funk,et al. Identifying Transmission Cycles at the Human-Animal Interface: The Role of Animal Reservoirs in Maintaining Gambiense Human African Trypanosomiasis , 2013, PLoS Comput. Biol..
[22] Jessica Sallander,et al. Conformational Toggle Switches Implicated in Basal Constitutive and Agonist-Induced Activated States of 5-Hydroxytryptamine-4 Receptors , 2009, Molecular Pharmacology.
[23] Hugh Rosen,et al. Crystal Structure of a Lipid G Protein–Coupled Receptor , 2012, Science.
[24] T. S. Kobilka,et al. Structural Insights into the Dynamic Process of β2-Adrenergic Receptor Signaling , 2015, Cell.
[25] Oliver P. Ernst,et al. Crystal structure of metarhodopsin II , 2011, Nature.
[26] Michael D. Davis,et al. Synthesis and biological evaluation of γ-aminophosphonates as potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonists , 2007 .
[27] S. Rasmussen,et al. A monoclonal antibody for G protein–coupled receptor crystallography , 2007, Nature Methods.
[28] J. Wess,et al. Activation and allosteric modulation of a muscarinic acetylcholine receptor , 2013, Nature.
[29] Rommie E. Amaro,et al. POVME 2.0: An Enhanced Tool for Determining Pocket Shape and Volume Characteristics , 2014, Journal of chemical theory and computation.
[30] Carsten Kutzner,et al. GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. , 2008, Journal of chemical theory and computation.
[31] K. Garcia,et al. Adrenaline-activated structure of the β2-adrenoceptor stabilized by an engineered nanobody , 2013, Nature.
[32] Manfred Burghammer,et al. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. , 2007, Nature.
[33] James G. Martin,et al. Sphingosine 1-Phosphate (S1P) Induced Interleukin-8 (IL-8) Release Is Mediated by S1P Receptor 2 and Nuclear Factor κB in BEAS-2B Cells , 2014, PloS one.
[34] A. Parrill,et al. S1P1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate. , 2005, Chemistry & biology.
[35] K. Dev,et al. The structure and function of the S1P1 receptor. , 2013, Trends in pharmacological sciences.
[36] Albert C. Pan,et al. The Dynamic Process of β2-Adrenergic Receptor Activation , 2013, Cell.
[37] R. Stevens,et al. Structure of an Agonist-Bound Human A2A Adenosine Receptor , 2011, Science.
[38] Irina Kufareva,et al. Chemokine and chemokine receptor structure and interactions: implications for therapeutic strategies , 2015, Immunology and cell biology.
[39] Christopher G. Tate,et al. The structural basis for agonist and partial agonist action on a β1-adrenergic receptor , 2010, Nature.
[40] Arthur J. Olson,et al. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..
[41] R. Proia,et al. Subcellular Origin of Sphingosine 1-Phosphate Is Essential for Its Toxic Effect in Lyase-deficient Neurons* , 2009, Journal of Biological Chemistry.
[42] Abby L Parrill,et al. Molecular recognition in the sphingosine 1-phosphate receptor family. , 2008, Journal of molecular graphics & modelling.
[43] Steven J Brown,et al. Sphingosine 1-phosphate receptor signaling. , 2009, Annual review of biochemistry.
[44] H. Rosen,et al. Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists , 2002, Science.
[45] S. Rasmussen,et al. Crystal Structure of the β2Adrenergic Receptor-Gs protein complex , 2011, Nature.
[46] D. Im. Discovery of new G protein-coupled receptors for lipid mediators Published, JLR Papers in Press, December 1, 2003. DOI 10.1194/jlr.R300006-JLR200 , 2004, Journal of Lipid Research.
[47] L. Pardo,et al. The pathway of ligand entry from the membrane bilayer to a lipid G protein-coupled receptor , 2016, Scientific Reports.
[48] S. Spiegel,et al. Identification of Edg1 Receptor Residues That Recognize Sphingosine 1-Phosphate* , 2000, The Journal of Biological Chemistry.
[49] M. Burghammer,et al. Crystal structure of the human β2 adrenergic G-protein-coupled receptor , 2007, Nature.
[50] Gianluigi Caltabiano,et al. Impact of Helix Irregularities on Sequence Alignment and Homology Modeling of G Protein‐Coupled Receptors , 2012, Chembiochem : a European journal of chemical biology.
[51] S. Rees,et al. A bioluminescent assay for agonist activity at potentially any G-protein-coupled receptor. , 1997, Analytical biochemistry.
[52] Saskia Nijmeijer,et al. A Structural Insight into the Reorientation of Transmembrane Domains 3 and 5 during Family A G Protein-Coupled Receptor Activation , 2011, Molecular Pharmacology.
[53] M. Babu,et al. Molecular signatures of G-protein-coupled receptors , 2013, Nature.
[54] Gianluigi Caltabiano,et al. Membrane Protein Simulations Using AMBER Force Field and Berger Lipid Parameters. , 2012, Journal of chemical theory and computation.
[55] D. Im. Intercellular Lipid Mediators and GPCR Drug Discovery , 2013, Biomolecules & therapeutics.
[56] M. Maceyka,et al. Extracellular and intracellular actions of sphingosine-1-phosphate. , 2010, Advances in experimental medicine and biology.